Benzinga | Nov 3, 2021 09:14AM EDT

HC Wainwright & Co. Maintains Buy on Evolus, Lowers Price Target to $15

HC Wainwright & Co. analyst Douglas Tsao maintains Evolus (NASDAQ:EOLS) with a Buy and lowers the price target from $22 to $15.